ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Birmingham, AL, USA:

Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

Brief Summary:The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adul...

Enrolling
Diabetes Mellitus, Type 2
Behavioral: Diabetes Education Class
Behavioral: Remote Patient Monitoring (RPM)
The University of Alabama at Birmingham
The University of Alabama at Birmingham

Birmingham, Alabama, United States

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Birmingham, Alabama, United States and 56 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Birmingham, Alabama, United States and 89 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Birmingham, Alabama, United States and 654 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Vestavia Hills, Alabama, United States and 103 other locations

weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Pelham, Alabama, United States and 138 other locations

This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...

Active, not recruiting
Type 2 Diabetes Mellitus
Biological: Insulin
Drug: Placebo to ertugliflozin 5 mg

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Birmingham, Alabama, United States and 103 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Cullman, Alabama, United States of America and 101 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes...

Enrolling
Diabetes Mellitus, Type 2
Drug: Retatrutide
Drug: Semaglutide

Phase 3

Lilly
Lilly

Birmingham, Alabama, United States and 79 other locations

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new inv...

Active, not recruiting
Type 2 Diabetes
Drug: Semaglutide
Drug: Cagrilintide

Phase 3

Novo Nordisk
Novo Nordisk

Birmingham, Alabama, United States and 185 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems